- Home
- APLT vs AUID Comparison
APLT vs AUID Comparison
Compare APLT & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | AUID |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 35.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLT | AUID |
|---|---|---|
| Price | $0.11 | $1.00 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.25 | N/A |
| AVG Volume (30 Days) | ★ 27.2M | 3.7M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,000,000.00 | ★ $1,834,458.00 |
| Revenue This Year | $124.18 | N/A |
| Revenue Next Year | $66.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 141.81 |
| 52 Week Low | $0.11 | $1.03 |
| 52 Week High | $1.50 | $9.58 |
Technical Indicators
Market Signals| Indicator | APLT | AUID |
|---|---|---|
| Relative Strength Index (RSI) | 25.17 | 30.73 |
| Support Level | $0.21 | $1.17 |
| Resistance Level | $0.26 | $1.38 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 7.83 | 9.23 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.